Perhaps: Humira (adalimumab) is an immune system modulator. No one would take this medication to turn down the immune system (with the potential that a new cancer might not be noticed) unless there was a greater problem at hand. If your rheumatoid arthritis is tolerable, as is, then please don't start on this medication. On the other hand, life is a series of trade-offs. Take this medicine if it is worth it.
Answered 10/9/2016
6.2k views
Unkown: Your risk of getting cancer mainly lymphoma is increased while on humira (adalimumab). It is more related to the duration of use. The dose for its use is usually 40mg subcutanous every 2 weeks, and I am not sure why one would double the dose. Your side effects certainly will get be worse with increased dose. Follow up with your rheumatologist is recommended.
Answered 7/29/2015
6.2k views
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question